MYCN and neuroblastoma: The baseline characteristics including age, gender, N-myc amplification, tumor cells percentage in the bone marrow, NSE, and year of diagnosis of patients with high-risk neuroblastoma dichotomized by AMC × ALC did not differ significantly between groups with exception of ferritin levels (Table 3).